Our scientists have significant expertise in all phases of medicinal chemistry, from intelligent molecule design to development of late-stage optimal molecular entities (OMEs) and preclinical candidates. Our experience ranges from idea generation and route scouting to synthetic route development and library synthesis. Whether the challenge requires re-synthesis of a competitor compound or a late stage lead optimization, we have the best experience and resources to meet or exceed customer expectations.
Our business model is flexible, and can be tailored to customer needs. We work either on a strict fee-for-service basis, or as part of a broader discovery collaboration to provide cost-effective services on an FTE basis. Our clients range from virtual and start-up companies to mid-size companies to multinational pharmaceutical companies. Since 2003, CreaGen has established a track record of excellence with satisfied customers ranging from multinational pharmaceutical companies to early-stage biotechnology start-up companies. CreaGen is poised for growth and we welcome the opportunity to help your organization to accomplish its most challenging research objectives.